300 related articles for article (PubMed ID: 18614291)
1. Intranasal anticonvulsive treatment: a prospective management of intractable epilepsy?
Tan L; Yu JT; Guan HS
Med Hypotheses; 2008 Oct; 71(4):542-5. PubMed ID: 18614291
[TBL] [Abstract][Full Text] [Related]
2. Molecular and cellular mechanisms of pharmacoresistance in epilepsy.
Remy S; Beck H
Brain; 2006 Jan; 129(Pt 1):18-35. PubMed ID: 16317026
[TBL] [Abstract][Full Text] [Related]
3. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy.
Kwan P; Brodie MJ
Epilepsia; 2005 Feb; 46(2):224-35. PubMed ID: 15679503
[TBL] [Abstract][Full Text] [Related]
4. [Drug-resistant epilepsy].
Nakken KO; Taubøll E
Tidsskr Nor Laegeforen; 2009 Oct; 129(19):1986-9. PubMed ID: 19823202
[TBL] [Abstract][Full Text] [Related]
5. Drug transporters in the epileptic brain.
Löscher W
Epilepsia; 2007; 48 Suppl 1():8-13. PubMed ID: 17316407
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of drug resistance.
Löscher W
Epileptic Disord; 2005 Sep; 7 Suppl 1():S3-9. PubMed ID: 16120487
[TBL] [Abstract][Full Text] [Related]
7. Focal treatment for refractory epilepsy: hope for the future?
Nilsen KE; Cock HR
Brain Res Brain Res Rev; 2004 Mar; 44(2-3):141-53. PubMed ID: 15003390
[TBL] [Abstract][Full Text] [Related]
8. Plasticity of antiepileptic drug targets.
Beck H
Epilepsia; 2007; 48 Suppl 1():14-8. PubMed ID: 17316408
[TBL] [Abstract][Full Text] [Related]
9. [The concept and treatment of drug-resistant intractable epilepsy].
Iváñez V
Rev Neurol; 1995; 23(124):1214-9. PubMed ID: 8556621
[TBL] [Abstract][Full Text] [Related]
10. Impaired mitochondrial energy production: the basis of pharmacoresistance in epilepsy.
Yuen AW; Sander JW
Med Hypotheses; 2011 Oct; 77(4):536-40. PubMed ID: 21737204
[TBL] [Abstract][Full Text] [Related]
11. [Mechanisms of drug resistance in epilepsy].
Lasoń W
Przegl Lek; 2006; 63(11):1218-20. PubMed ID: 17348420
[TBL] [Abstract][Full Text] [Related]
12. Management of epilepsy in oncological patients.
Villanueva V; Codina M; Elices E
Neurologist; 2008 Nov; 14(6 Suppl 1):S44-54. PubMed ID: 19225370
[TBL] [Abstract][Full Text] [Related]
13. Money matters in epilepsy.
Thomas SV
Neurol India; 2000 Dec; 48(4):322-9. PubMed ID: 11146594
[TBL] [Abstract][Full Text] [Related]
14. [Experimental basis for the treatment of drug-resistant epilepsy].
Błaszczyk B; Trojnar M; Czuczwar SJ
Przegl Lek; 2006; 63(11):1221-3. PubMed ID: 17348421
[TBL] [Abstract][Full Text] [Related]
15. [Medications, epileptic crises, and epilepsy].
Jallon P; Perrig S
Rev Med Suisse Romande; 2003 Jan; 123(1):11-5. PubMed ID: 15095721
[TBL] [Abstract][Full Text] [Related]
16. [Effect of melatonin on intractable epilepsies].
Saracz J; Rosdy B
Orv Hetil; 2004 Dec; 145(51):2583-7. PubMed ID: 15715292
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular protective effect of melatonin in sudden unexpected death in epilepsy: a hypothesis.
Scorza FA; Colugnati DB; Arida RM; de Lima E; Naffah-Mazzacoratti Mda G; Cavalheiro EA; Amado D
Med Hypotheses; 2008; 70(3):605-9. PubMed ID: 17683875
[TBL] [Abstract][Full Text] [Related]
18. [Basic considerations in the treatment of epileptic patients (author's transl)].
Scollo-Lavizzari G; Matthis H
Wien Klin Wochenschr Suppl; 1980; 121():13-7. PubMed ID: 6936988
[TBL] [Abstract][Full Text] [Related]
19. The safety and tolerability of intranasal midazolam in epilepsy.
Mula M
Expert Rev Neurother; 2014 Jul; 14(7):735-40. PubMed ID: 24910118
[TBL] [Abstract][Full Text] [Related]
20. ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy.
Vezzani A; Balosso S; Maroso M; Zardoni D; Noé F; Ravizza T
Curr Opin Investig Drugs; 2010 Jan; 11(1):43-50. PubMed ID: 20047158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
